CT Screening for Lung Cancer: Diagnoses Resulting from the New York Early Lung Cancer Action Project

    Purpose: To evaluate prospectively the diagnostic performance of the New York Early Lung Cancer Action Project (NY-ELCAP) regimen in the diagnosis of early lung cancer at baseline and annual repeat computed tomographic (CT) screenings.

    Materials and Methods: Informed consent and institutional review board approval were obtained for this HIPAA-compliant study of baseline and annual repeat low-dose CT screening performed with a common regimen in asymptomatic individuals at 12 institutions in New York State. All 6295 participants were aged 60 years or older, had smoked for at least 10 pack-years, had no prior cancer, had not undergone chest CT in the previous 3 years, and were medically fit to undergo thoracic surgery. Median age was 66 years, and median smoking history was 40 pack-years. The proportion (and 95% exact confidence intervals [CIs]) of subjects with a positive result, as determined by using nodule size; the diagnoses of lung cancer resulting from subsequent work-up; and the distribution by cancer stage and cell type were determined. When relevant, 95% CIs for the proportions were calculated.

    Results: Initial CT imaging led to recommendations for further work-up in 14.4% (95% CI: 13.5%, 15.3%) of the 6295 baseline screenings and 6.0% (95% CI: 5.1%, 6.6%) of the 6014 annual repeat screenings. Of 101 patients in whom the diagnosis of lung cancer resulted from baseline screening and three in whom a diagnosis of lung cancer was prompted by symptoms prior to the first scheduled repeat screening, 95 (91.3%) had no clinical evidence of metastases. Of the 20 patients in whom the diagnosis of lung cancer resulted from annual repeat screening, 17 (85%) showed no evidence of metastases. Of the 134 recommended biopsies, 125 (93.3%) resulted in diagnosis of lung cancer or another malignancy, while none of the 24 biopsies performed outside of the recommendation of the regimen resulted in diagnosis of lung cancer.

    Conclusion: The NY-ELCAP regimen of screening revealed that annual CT screening for lung cancer resulted in identification of a high proportion of patients with early-stage disease.

    © RSNA, 2007

    References

    • 1 Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354: 99–105.
    • 2 Grady D. CAT scan process could cut deaths from lung cancer. New York Times. July 9, 1999;1.
    • 3 Henschke CI, Naidich DP, Yankelevitz DF, et al. Early Lung Cancer Action Project: initial findings on annual repeat screenings. Cancer 2001;92:153–159.
    • 4 Henschke CI, Miettinen OS, Yankelevitz DF, Libby D, Smith JP. Radiographic screening for cancer: proposed paradigm for requisite research. Clin Imaging 1994;18:16–20.
    • 5 Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS. The use of spiral CT in lung cancer screening. In: DeVita VT, Hellman S, Rosenberg SA, eds. Progress in oncology 2002. Sudbury, Mass: Jones & Barlett, 2002; 90–101.
    • 6 Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley DI, Miettinen OS. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002;178:1053–1057.
    • 7 Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology 2004;231:164–168.
    • 8 Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS. Screening for lung cancer: the Early Lung Cancer Action approach. Lung Cancer 2002;35:143–148.
    • 9 International Early Lung Cancer Action protocol (including flowcharts). http://www.IELCAP.org. Accessed January 29, 2007.
    • 10 Henschke CI, Yankelevitz DF, Smith JP, et al. CT screening for lung cancer: assessing a regimen's diagnostic performance. Clin Imaging 2004;28:317–321.
    • 11 Reeves AP, Kostis WJ, Yankelevitz DF, Henschke CI. A Web-based database system for multi-institutional research studies on lung cancer [abstr]. Radiology 2001;221(P):372.
    • 12 MacMahon H, Austin JM, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237:395–400.
    • 13 Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology 2000;217:251–256.
    • 14 Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Three-dimensional segmentation and growth-rate estimation of small pulmonary nodules in helical CT images. IEEE Trans Med Imaging 2003;22:1259–1274.
    • 15 Kostis WJ, Yankelevitz DF, Reeves AP, Fluture SC, Henschke CI. Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 2004;231:446–452.
    • 16 Vazquez M, Flieder D, Travis W, et al. Early Lung Cancer Action Project pathology protocol. Lung Cancer 2003;39:231–232.
    • 17 Vazquez M, Flieder D, Travis W, et al. Early Lung Cancer Action Project pathology protocol. http://www.IELCAP.org. Accessed January 29, 2007.
    • 18 Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. World Health Organization classification of tumours: pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon, France: IARC, 2004.
    • 19 American Joint Committee on Cancer (AJCC). Lung. In: Fleming ID, Cooper JS, Hensen DE, et al, eds. Cancer staging manual. 5th ed. Philadelphia, Pa: Lippincott-Raven, 1997; 127.
    • 20 Consensus of the 10th International Conference on Screening for Lung Cancer. http://www.IELCAP.org. Accessed January 29, 2007.
    • 21 Shaham D, Breuer R, Coppel L, et al. Computed tomography screening for lung cancer: applicability of an international protocol in a single-institution environment. Clin Lung Cancer 2006;7:262–267.
    • 22 Bastarrika G, Garcia Velloso MJ, Lozano MD, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 2005;171:1378–1383.
    • 23 Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351:1242–1245.
    • 24 Sone S, Li F, Yang ZG, et al. Results of 3-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001;84:25–32.
    • 25 Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol 2002;20:911–920.
    • 26 Diederich S, Wormanns D, Semik M, et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 2002;222:773–781.
    • 27 Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508–513.
    • 28 Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS. Small stage I cancers of the lung: genuineness and curability. Lung Cancer 2003;39:327–330.
    • 29 The International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763–1771.
    • 30 American Cancer Society. Statistics 2005: cancer facts and figures. http://www.cancer.org. Accessed October 11, 2005.

    Article History

    Published in print: 2007